the Prognostic value of serum prolactin (PRL), testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) and inflammatory markers in Obese Patients With Polycystic Ovary Syndrome after treatment with Clomiphene citrate , antihyperglyc
Prognostic value of serum prolactin (PRL), testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) and inflammatory markers
Abstract
Aim: Polycystic ovary syndrome is a very common endocrine and metabolic disease in clinical practice. Most polycystic ovary syndrome patients are complicated with obesity, a condition associated with an elevated risk of long-term complications such as diabetes, hypertension, and endometrial cancer, seriously threatening the health of patients. The best way to treat this disease is to use drugs to promote ovulation, adjust the menstrual period, and restore pregnancy. However, the drugs used to treat obesity and polycystic ovary syndrome usually have completely opposite effects, resulting in unsatisfactory rehabilitation.
Methods: This study selected 102 obese PCOS patients treated in our hospital from July 2022 to July 2024 as the research subjects. Sex hormones: The levels of prolactin (PRL), testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were measured by electrochemiluminescence. Inflammation: C-reactive protein (CRP), white blood cell count (WBC), and procalcitonin (PCT) were examined by an automated blood cell counter. 46 (control group) of the 102 were treated with conventional treatment scheme, and the other 46 (experimental group) were intervened by nutritional intervention based on conventional treatment.
Results: Both groups showed reductions in sex hormone levels after treatment, with the PRL, T, LH, and FSH in the experimental group being (5.12±0.51)mIU/mL, (1.22±0.32)nmol/L, (9.14±1.61)IU/L, and (5.01±0.42)IU/L, respectively, all of which were lower compared with the control group (P<0.05).
Conclusion: In this study, we intervened obese polycystic ovary syndrome patients with nutritional or conventional intervention and found that compared with conventional treatment, the posture, blood glucose metabolism, and lipid function of the patients who received nutritional intervention were more significantly metabolized, and the levels of inflammatory factors were more effectively inhibited, indicating the high clinical application value of nutritional intervention in obese polycystic ovary syndrome.
References
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology (2018). ACOG practice bulletin No. 194: Polycystic ovary syndrome. Obstetrics and Gynecology 131:e157-e171. doi: 10.1097/AOG.0000000000002656
Azziz R. (2018). Polycystic ovary syndrome. Obstetrics and Gynecology 132:321-336. doi: 10.1097/AOG.0000000000002698
Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A and Savastano, S. (2019). Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients 11:2278. doi: 10.3390/nu11102278
Calcaterra, V., Verduci, E., Cena, H., Magenes, V.C., Todisco, C.F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E and Zuccotti, G. (2021). Polycystic ovary syndrome in insulin-resistant adolescents with obesity: The role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients 13:1848. doi: 10.3390/nu13061848
Che, X., Chen, Z., Liu, M and Mo, Z. (2021). Dietary interventions: A promising treatment for polycystic ovary syndrome. Annals of Nutrition and Metabolism 77:313-323. doi: 10.1159/000519302
Dabravolski, S.A., Nikiforov, N.G., Eid, A.H., Nedosugova, L.V., Starodubova, A.V., Popkova, T.V., Bezsonov, E.E and Orekhov, A.N. (2021). Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. International Journal of Molecular Sciences 22:3923. doi: 10.3390/ijms22083923
DiVall, S and Merjaneh, L. (2019). Adolescent polycystic ovary syndrome: An update. Pediatric Annals 48:e304-e310. doi: 10.3928/19382359-20190729-01
Escobar-Morreale H.F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews. Endocrinology 14:270-284. doi: 10.1038/nrendo.2018.24
Kazemi, M., Kim, J.Y., Wan, C., Xiong, J.D., Michalak, J., Xavier, I.B., Ganga, K., Tay, C.T., Grieger, J.A., Parry, S.A., Moran, L.J and Lujan, M.E. (2022). Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women. Human Reproduction Update 28:910-955. doi: 10.1093/humupd/dmac023
Kiani, A. K., Donato, K., Dhuli, K., Stuppia, L and Bertelli, M. (2022). Dietary supplements for polycystic ovary syndrome. Journal of Preventive Medicine and Hygiene 63:E206-E213. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2762
Liu, D., Gao, X., Pan, X. F., Zhou, T., Zhu, C., Li, F., Fan, J. G., Targher, G and Zhao, J. (2023). The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Medicine 21:62. doi: 10.1186/s12916-023-02775-0
Macut, D., Bjekić-Macut, J., Rahelić, D and Doknić, M. (2017). Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice 130:163-170. doi: 10.1016/j.diabres.2017.06.011
Ortiz-Flores, A.E., Luque-Ramírez, M and Escobar-Morreale, H.F. (2019). Polycystic ovary syndrome in adult women. Síndrome de ovario poliquístico en la mujer adulta. Medicina Clinica 152:450-457. doi: 10.1016/j.medcli.2018.11.019
Sadeghi, H.M., Adeli, I., Calina, D., Docea, A.O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A and Abdollahi, M. (2022). Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. International Journal of Molecular Sciences 23:583. doi: 10.3390/ijms23020583
Shang, Y., Zhou, H., Hu, M and Feng, H. (2020). Effect of diet on insulin resistance in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 105:dgaa425. doi: 10.1210/clinem/dgaa425
Szczuko, M., Kikut, J., Szczuko, U., Szydłowska, I., Nawrocka-Rutkowska, J., Ziętek, M., Verbanac, D and Saso, L. (2021). Nutrition strategy and life style in polycystic ovary syndrome-narrative review. Nutrients 13:2452. doi: 10.3390/nu13072452
Szczuko, M., Skowronek, M., Zapałowska-Chwyć, M and Starczewski, A. (2016). Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS). Roczniki Panstwowego Zakladu Higieny 67:419-426.
Copyright (c) 2025 Xinqin Kang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.